ARNOLD & PORTER KAYE SCHOLER LLP

Lobbying for NOVO NORDISK A/S · Novo Nordisk A/S is the parent of the Novo Nordisk group, a global healthcare company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · posted Apr 17, 2025

Lobbying activity 2

Manufacturing

Issues related to manufacturing capacity and supply chain resiliency.

Health Issues

Issues related to manufacturing capacity and supply chain resiliency.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.